Navigation Links
Lumetra Announces Sale of Subsidiary IntegriGuard
Date:9/30/2009

Sale Allows Healthcare Consulting Organization to Focus on Core Business

SAN FRANCISCO, Sept. 30 /PRNewswire/ -- Lumetra, the San Francisco-based healthcare solutions consulting organization, announced today the completion of the sale of its IntegriGuard subsidiary to HMS (Nasdaq: HMSY), a publicly traded company.

In making the announcement, Linda M. Sawyer, Ph.D., RN, Lumetra's Chief Executive Officer, stated: "The sale of IntegriGuard is a significant milestone in the implementation of our strategic plan and allows Lumetra to focus on our core business and clients, driving the advancement of healthcare through evidence-based solutions and technology."

IntegriGuard was formed in 1999 as a national division of Lumetra focusing on the prevention and detection of fraud and abuse in healthcare systems. It was established as a wholly-owned subsidiary in April 2003. The sale is effective immediately.

About Lumetra

Lumetra provides reliable professional services and sustainable solutions through integrated clinical, technological, and analytic expertise to transform the delivery and administration of healthcare. For more information, please visit www.lumetra.com.

SOURCE Lumetra


'/>"/>
SOURCE Lumetra
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Lumetra Program Improves Diabetes Care Among Latinos
2. UCSF Announces Expanded BreastCancerTrials.org Website
3. DSS Research Announces Senior Health Risk Assessment (SrHRA)(TM)
4. US Farms, Inc. Announces Distribution Partnership With Natures Best
5. Datafarm™ Announces HollisterStier Contract Manufacturing Regulatory Affairs Deploys S-Cubed eCTD
6. Hutchinson Metro Center Announces Over 50,000 SF in New Leases for Medical Space at Bronx Complex
7. President Announces Free Health Plan
8. NovoCure Ltd. announces closing of financing round
9. RCRC Independent Review Board Announces DHHS Research Oversight
10. change:healthcare Announces Twitter Application that brings Healthcare Information and Costs to Consumers' Fingertips
11. QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: